« Back to Record
Citation APA

Hortobagyi, G. N., Deleu, I., Shtivelband, M., Masuda, N., Dakhil, S., Anderson, I., Robinson, D. D., He, W., Garg, A., McDonald, R. E., Bitter, H., Chen, D., Huang, A., Taran, T., Bachelot, T., Lebrun, F., Lebwohl, D., Baselga, J., Piccart-Gebhart, M., Rugo, H., Burris, H. H., Pritchard, K., Campone, M., Noguchi, S., & Perez, A. (2016). Correlative analysis of genetic alterations and everolimus benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Results from BOLERO-2. Journal of clinical oncology, 34(5), 419-426. doi:10.1200/JCO.2014.60.1971


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231186

Hortobagyi, G. N., Deleu, I., Shtivelband, M., Masuda, N., Dakhil, S., Anderson, I., Robinson, D. D., He, W., Garg, A., McDonald, R. E., Bitter, H., Chen, D., Huang, A., Taran, T., Bachelot, T., Lebrun, F., Lebwohl, D., Baselga, J., Piccart-Gebhart, M., Rugo, H., Burris, H. H., Pritchard, K., Campone, M., Noguchi, S., & Perez, A. (2016). Correlative analysis of genetic alterations and everolimus benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Results from BOLERO-2. Journal of clinical oncology, 34(5), 419-426. doi:10.1200/JCO.2014.60.1971